ATC code L02
From Wikipedia, the free encyclopedia
| ATC codes |
|---|
| L Antineoplastic and immunomodulating agents |
| L01 Antineoplastic agents |
| L02 Endocrine therapy |
| L03 Immunostimulants |
| L04 Immunosuppressants |
|
A • B • C • D • G • H • QI • J • L • M • N • P • R • S • V |
ATC code L02 Endocrine therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup L02 is part of the anatomical group L Antineoplastic and immunomodulating agents.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QL02...[2]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
Contents |
[edit]
[edit] L02AA Estrogens
- L02AA01 Diethylstilbestrol
- L02AA02 Polyestradiol phosphate
- L02AA03 Ethinylestradiol
- L02AA04 Fosfestrol
[edit] L02AB Progestogens
- L02AB01 Megestrol
- L02AB02 Medroxyprogesterone
- L02AB03 Gestonorone
[edit] L02AE Gonadotropin-releasing hormone analogues
- L02AE01 Buserelin
- L02AE02 Leuprorelin
- L02AE03 Goserelin
- L02AE04 Triptorelin
[edit] L02AX Other hormones
[edit]
[edit] L02BA Anti-estrogens
- L02BA01 Tamoxifen
- L02BA02 Toremifene
- L02BA03 Fulvestrant
[edit] L02BB Anti-androgens
- L02BB01 Flutamide
- L02BB02 Nilutamide
- L02BB03 Bicalutamide
[edit] L02BG Aromatase inhibitors
- L02BG01 Aminogluthetimide
- L02BG02 Formestane
- L02BG03 Anastrozole
- L02BG04 Letrozole
- L02BG05 Vorozole
- L02BG06 Exemestane
[edit]
- L02BX01 Abarelix
- L02BX02 Degarelix
- L02BX03 Abiraterone
[edit] References
- ^ "ATC/DDD Index 2012". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc_ddd_index/.
- ^ "ATCvet Index 2011". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcvet/atcvet_index/.
|
||||||||||||||||||||||||||||||||||||||||||||||||
